Burden of Gastrointestinal Disease in the United States: 2012 Update

By A. Peery, E. Dellon, J. Lund, Seth D. Crockett, C. McGowan, W. Bulsiewicz, L. Gangarosa, M. Thiny, Karyn Stizenberg, D. Morgan and 9 more. Gastroenterology, 2012

1,992 citations recorded by the source corpus.

Background & Aims Gastrointestinal (GI) diseases account for substantial morbidity, mortality and cost. Statistical analyses of the most recent data are necessary to guide GI research, education and clinical practice. We estimate the burden of GI disease in the US. Methods We collected information on the epidemiology of GI diseases (including cancers) and symptoms, along with data on resource utilization, quality of life, impairments to work and activity, morbidity, and mortality. These data were obtained from the National Ambulatory Medical Care Survey; National Health and Wellness Survey; Nationwide Inpatient Sample; Surveillance, Epidemiology, and End Results Program; National Vital Statistics System; Thompson Reuters MarketScan®; Medicare; Medicaid; and the Clinical Outcomes Research Initiative’s National Endoscopic Database. We estimated endoscopic use and costs and examined trends in endoscopic procedure. Results Abdominal pain was the most common gastrointestinal symptom that prompted a clinic visit (15.9 million visits). Gastroesophageal reflux was the most common GI diagnosis (8.9 million visits). Hospitalizations and mortality from Clostridium difficile infection have doubled in the last 10 years. Acute pancreatitis was the most common reason for hospitalization (274,119 discharges). Colorectal cancer accounted for more than half of all GI cancers and was the leading cause of GI-related mortality (52,394 deaths). There were 6.9 million upper, 11.5 million lower, and 228,000 biliary endoscopies performed in 2009. The total cost for outpatient gastrointestinal endoscopy examinations was $32.4 billion. Conclusions GI diseases are a source of substantial morbidity, mortality and cost in the US.

Subfields: Epidemiology, Genetics, Oncology

View Paper: https://www.semanticscholar.org/paper/6a54718cab18914593c2e4da70aace0b404cc02d

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Oncology

Citations in the corpus

Presentation and Epidemiology of Gastroesophageal Reflux Disease (2017, background): “(2) Although complications such as bleeding erosive esophagitis or peptic stricture are becoming less common, individuals with GERD symptoms have a decrement in their quality of life that is similar to patients with inflammatory bowel disease.(2) To accurately diagnose and manage”
Quality Indicators for Colonoscopy (2015, background): “3 million outpatient colonoscopies are performed annually in the United States, with screening and polyp surveillance accounting for half of indications.(2) Optimal effectiveness of colonoscopy depends on patient acceptance of the procedure, which depends mostly on acceptance of the bowel preparatio”
IAP/APA evidence-based guidelines for the management of acute pancreatitis. (2013, background): “at SciVerse ScienceDirect Contents lists available Pancreatology journal homepage: www.elsevier .com/locate/pan Original article IAP/APA evidence-based guidelines for the management of acute pancreatitis Working Group IAP/APA Acute Pancreatitis Guidelinesa,b,*,1 a International Association of Pancre”